Quantitative C-reactive protein in pulmonary infections

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Clinical Diagnostics

Background:

• Pulmonary infections encompass a range of conditions with varying etiologies.
• Accurate diagnosis and monitoring of treatment response are crucial for effective management.
• C-reactive protein (CRP) is a known biomarker for inflammation.

Purpose of the Study:

• To evaluate the diagnostic utility of C-reactive protein (CRP) in differentiating various pulmonary infections.
• To assess the correlation between CRP levels, causative pathogens, and inflammation severity.
• To determine the role of serial CRP measurements in monitoring treatment efficacy in bacterial pneumonia.

Main Methods:

• Retrospective analysis of 207 patient cases with confirmed pulmonary infections.
• Measurement and comparison of mean C-reactive protein (CRP) values across different infection types.
• Monitoring of serial CRP levels in a subset of patients with treated bacterial pneumonia.

Main Results:

• Distinct mean CRP levels were observed for tuberculosis (exudative-fibrotic, pneumonia, effusion, cavity, miliary), mycoplasmal pneumonia, bacterial pneumonia (with and without effusion), and lung abscess.
• Significantly elevated CRP levels were noted in bacterial pneumonia and lung abscess compared to tuberculous and other infections.
• Serial CRP levels in bacterial pneumonia demonstrated a decrease by day 3-4 and normalization by day 10-13 post-treatment initiation.

Conclusions:

• C-reactive protein (CRP) levels exhibit differential patterns across various pulmonary infections, aiding in diagnosis.
• The magnitude of CRP elevation is influenced by both the specific pathogen and the inflammatory response severity.
• Serial CRP monitoring provides a valuable tool for assessing treatment response in bacterial pneumonia.